Skønnene over udbredelsen af brugen af forskellige former for nye stoffer er meget lavere end skønnene over brugen af de mere gængse illegale stoffer.
Prevalence estimates for the use of new or emerging drugs are much lower than those for the use of more established illicit drugs.